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Introduction
The vertebrate inner ear is a complex structure comprised of 
the auditory (cochlear) and balance (vestibular) systems, which 
are responsible for perception of sound and gravitational/angu-
lar acceleration (Driver and Kelley, 2009), respectively. Aris-
ing from a simple epithelium, the otic placode, the inner ear 
undergoes extensive morphogenesis and differentiation, ulti-
mately giving rise to many different cell types that are arranged 
to form an organ of exquisite complexity (Christophorou et al., 
2010; Chen and Streit, 2013). Comprised of cells as diverse 
as mechanosensory hair cells, sensory neurons, and support 
cells, defects in inner ear development lead to hearing loss and 
balance disorders, which are among the most common of live 
birth defects (Stevens et al., 2013; Van Kerschaver et al., 2013; 
Emmett and West, 2014).
The otic placode begins as a thickening of the ectoderm 
adjacent to the developing hindbrain. As development proceeds, 
the placode invaginates to form the otic pit that subsequently de-
velops into a cup that pinches off the ectoderm and closes dor-
sally to form the otic vesicle (otocyst). Invagination of placode 
cells to form the otocyst requires extensive cell shape changes, 
cell movements, and rearrangements that require remodeling of 
cell–matrix and cell–cell interactions among otic cells, as well 
as with the adjacent hindbrain (Gerchman et al., 1995; Brown et 
al., 1998; Moro-Balbás et al., 2000; Visconti and Hilfer, 2002). 
As development proceeds, the otic vesicle becomes regional-
ized, undergoes extensive proliferation, and finally differentiates 
into the vestibular and cochlear components of the inner ear 
(Barald and Kelley, 2004; Neves et al., 2013). In the chick em-
bryo, formation of a detectable otic placode is first apparent 
next to rhombomeres 5 and 6 of the hindbrain by Hamburger 
and Hamilton stage 10, by which time otic specification is com-
plete. Invagination begins at stage 12, resulting in the formation 
of an otic cup that closes to form the internalized otic vesicle 
by stages 18–20 (Alvarez and Navascués, 1990; Streit, 2002; 
Barald and Kelley, 2004; Sai and Ladher, 2008; Sai et al., 2014).
Understanding the molecular mechanisms that regulate 
the spatiotemporal expression of genes involved in otic placode 
development is critical for elucidating both normal develop-
ment and defects that may lead to hearing impairment. Numer-
ous transcription factors, including Pax2, Dlx3, Dlx5, Nkx5.1, 
SOHo1, and Sox10, have been implicated in various aspects of 
ear development, primarily with respect to their roles in otic 
specification and subsequent differentiation (Deitcher et al., 
1994; Baker and Bronner-Fraser, 2001; Brown et al., 2005; 
Barembaum and Bronner-Fraser, 2010; Christophorou et al., 
2010). For example, Pax2 expression initiates within the early 
otic placode at stage 8 and plays an essential role in its speci-
fication (Christophorou et al., 2010; Groves and Fekete, 2012), 
whereas Sox10 is expressed later and is likely involved in dif-
ferentiation events (Cheng et al., 2000; Dutton et al., 2009). 
In contrast to the role of transcriptional regulation during ear 
development, virtually nothing is known about the role of epi-
genetic regulators therein.
In vertebrates, the inner ear arises from the otic placode, a thickened swathe of ectoderm that invaginates to form the 
otic vesicle. We report that histone demethylase KDM4B is dynamically expressed during early stages of chick inner ear 
formation. A loss of KDM4B results in defective invagination and striking morphological changes in the otic epithelium, 
characterized by abnormal localization of adhesion and cytoskeletal molecules and reduced expression of several inner 
ear markers, including Dlx3. In vivo chromatin immunoprecipitation reveals direct and dynamic occupancy of KDM4B 
and its target, H3K9me3, at regulatory regions of the Dlx3 locus. Accordingly, coelectroporations of DLX3 or KDM4B 
encoding constructs, but not a catalytically dead mutant of KDM4B, rescue the ear invagination phenotype caused by 
KDM4B knockdown. Moreover, a loss of DLX3 phenocopies a loss of KDM4B. Collectively, our findings suggest that 
KDM4B play a critical role during inner ear invagination via modulating histone methylation of the direct target Dlx3.
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In this study, we report that lysine-specific demethylase 
4B, KDM4B (also known as JmjD2B), is expressed in the devel-
oping otic placode, consistent with a possible role as an epigen-
etic modifier of inner ear development. The KDM4/JumonjiD2 
family of histone lysine demethylases removes H3K9me3/me2 
and H3K36me3/me2 methylation marks (Couture et al., 2007; 
Tan et al., 2008) and thus activates or represses expression of 
target genes, respectively. Despite their likely importance as 
epigenetic regulators, surprisingly little is known about the 
developmental roles of the KDM4 family or other epigenetic 
modifiers in vivo (Strobl-Mazzulla et al., 2010). Here, we show 
that KDM4B is necessary for proper invagination of the otic 
placode, with its loss resulting in malformed placodes that fail 
to form vesicles of the proper size and shape. In vivo chromatin 
immunoprecipitation (ChIP) further demonstrates that the Dlx3 
gene, previously hypothesized to play a role in placode invagi-
nation (Brown et al., 2005), is a direct target of KDM4B. These 
results reveal for the first time an epigenetic contribution to the 
control of inner ear invagination in vertebrate embryos via mod-
ulation of histone methylation.
Results
KDM4B is expressed during chick otic 
placode specification/invagination, and its 
loss of function results in abnormal 
maintenance of H3K9me3 marks
As we previously detected Kdm4b expression by quantitative 
PCR (qPCR) in the early embryos at the time of otic placode 
formation (Strobl-Mazzulla et al., 2010), we analyzed the spa-
tial expression of Kdm4b by whole-mount in situ hybridization 
(ISH). We confirmed that Kdm4b is expressed in presumptive 
otic ectoderm by stage 9 (6 somite stage [ss]), persists through 
stage 9 (8ss), and by stage 12 (16ss) is confined to the border 
of the otocyst (Fig. 1 and Fig. S1). We compared the expres-
sion of Kdm4b transcripts by whole-mount ISH from stages 
11 and 13 with the early inner ear marker PAX2. At stage 11 
(Fig. 1 A), Kdm4b expression overlaps with PAX2 (Fig. 1 C). 
However, by stage 13, Kdm4b expression shifts to the edges of 
the invaginating otocyst (Fig. 1 B), only minimally overlapping 
with a few PAX2-positive cells (Fig. 1 D). These observations 
indicate that Kdm4b is dynamically expressed during the in-
vagination phases of otic development, raising the possibility 
that histone demethylation via KDM4B may occur in a stage- 
and site-specific manner.
Next, we assessed the distribution of the KDM4B sub-
strate H3K9me3 by immunohistochemistry at similar stages 
of otic development. At stage 11, H3K9me3-positive cells 
were detected throughout the otic placode (Fig.  2  A); how-
ever, by stage 13, the mark was largely confined to cells along 
the edges of the invaginating otic vesicle (Fig.  2  B). These 
results reveal in vivo dynamic spatial distribution of both the 
H3K9me3 epigenetic mark and Kdm4b transcripts in the otic 
and invaginating placode.
The correlation of the spatial localization of Kdm4b at 
stages 11 and 13 (Fig. 1) with changes in H3K9me3 distribu-
tion raised the intriguing possibility that KDM4B may be re-
sponsible for removal of the triple methylation mark during otic 
placode invagination. To test this, we performed KDM4B loss-
of-function experiments by electroporating a fluorescein-tagged 
antisense morpholino (MO) into the right otic ectoderm of stage 
8 embryos, leaving the left side as an internal control. Immu-
nostaining revealed the persistence of the H3K9m3 epigenetic 
mark at stage 13 throughout the entire placode region on the 
KDM4B-MO–treated side (Fig. 2, E and F) compared with the 
control side, where the mark was restricted to the edges of the 
otocyst (Fig. 2, C and D). These results show that KDM4B is 
necessary for removal of the repressive H3K9me3 methylation 
mark in the developing ear.
KDM4B loss of function results in ear 
deformities and reduction in marker  
gene expression
The dynamic expression of Kdm4b and its substrate is consis-
tent with the possibility that KDM4B plays an important role 
in regulating otic vesicle development. To further test this, we 
performed loss-of-function experiments at stage 8 as described 
in the previous section and examined embryos at stage 13 for 
the expression of the ear markers Dlx3, SOHo1, Pax2, and 
Sox10 by ISH. Whole-mount and section analyses revealed that 
KDM4B-MO–electroporated otic vesicles were deformed in 
shape and exhibited a reduction in the expression domains of all 
inner ear markers examined when compared with the uninjected 
Figure 1. Kdm4b is expressed during otic placode specification/invagination. (A and B) ISH of chick embryos at stages 11 (A) and 13 (B) with an 
antisense probe for Kdm4b transcripts. A’ and B’ are magnifications in the region of interest. A’’ and B’’ are transverse sections, as indicated by the 
dotted lines in A and B.  (C and D) Immunostaining with the PAX2 antibody on transverse sections through Kdm4b in situ hybridized embryos reveal 
overlap of PAX2 and Kdm4b expression throughout the otic ectoderm at stage 11 (C) that diminishes by stage 13 (D), when kdm4b becomes restricted to 
the edges. Bars, 200 µm.
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side of the same embryo (Fig.  3, A–D) or with control-MO–
treated embryos (Fig. 3, E–H). Embryos were categorized ac-
cording to the severity of the ear reduction phenotype as strong, 
mild, or none (Fig. S2, A–C). Some of the phenotypes observed 
were so severe that there was no sign of an otic vesicle, and 
SOHo1 expression was completely absent (Fig. S2 A). For 
all of the genes analyzed, we observed a significant increase 
in the severity of the phenotypes compared with control-MO–
treated embryos (Fig. S2 D). To further analyze the reduction 
of the otic domain, we quantified the expression of Dlx3, Pax2, 
SOHo1, and Sox10 transcripts by qPCR from stage 13 otic vesi-
cles that were electroporated with KDM4B-MO compared with 
uninjected vesicles. The results show a consistent reduction in 
the expression of SOHo1 and Dlx3 genes caused by the deple-
tion of KDM4B, with less obvious changes for Sox10 and Pax2 
(Fig. 3 I). It is interesting to note that on the dissected tissue used 
for this experiment, SOHo1 and Dlx3 are exclusively expressed 
in the otic placode cells, whereas Sox10 and Pax2 are also ex-
pressed in surrounding tissues such as neural crest and epibran-
chial placode cells, respectively. To demonstrate the specificity 
of the MO, we performed a Western blot analysis that confirmed 
a marked reduction of KDM4B protein after MO knockdown 
on the injected compared with uninjected sides of the same em-
bryos (Fig. 3 J). In addition, we performed rescue experiments 
in which KDM4B-MO was coelectroporated with an expres-
sion vector containing a KDM4B coding sequence. The result 
showed a significant attenuation (P < 0.01) in the severity of 
the phenotypes compared with KDM4B-MO plus an empty 
vector (Fig. 3, K and L; and Fig. S2 E). However, when a vec-
tor containing a catalytically dead mutant version of KDM4B 
(KDM4BΔ) was coelectroporated with the KDM4B-MO, there 
was no rescue, demonstrating that catalytic activity of the en-
zyme plays a critical role (Fig. 3 M and Fig. S2 E).
Collectively, these results demonstrate that KDM4B de-
methylation activity is required for the correct expression of 
several ears markers, and its perturbation causes profound de-
fects in inner ear formation, highlighting the importance of epi-
genetic regulation during this process.
Depletion of KDM4B protein transiently 
increases cell proliferation and cell death
The striking change in otic vesicle morphology and ear 
marker gene expression after a reduction of KDM4B levels 
suggests that proper levels of this demethylase are required 
for the cellular mechanisms underlying inner ear growth 
and morphogenesis. To assess whether the otic phenotype of 
KDM4B-MO–treated embryos might result from a defect in 
cell proliferation, we performed BrdU incorporation assays to 
assess S-phase occupancy, as well as cell counts using Hoechst 
staining and phosphohistone H3 (pH3) immunostaining to an-
alyze mitotic activity at different stages (Fig. 4). At stage 11, 
BrdU incorporation assays revealed a slight but significant 
increase in the number of S-phase cells (P = 0.0488), with 
control otic vesicle sections containing a mean of 42 ± 4.76 
positive cells and KDM4B-MO–injected vesicles containing 
55 ± 2.27 BrdU-positive cells (Fig. 4, A, D, and G). Total cell 
counts revealed a corresponding increase in the mean num-
ber of cells within the otic placode domain at stage 12, with 
control otic sections containing a mean of 97.4 ± 1.63 cells, 
whereas KDM4B-MO–injected vesicles had a mean of 123.8 
± 9.02 cells (P = 0.0205; Fig.  4, B, E, and H). In addition, 
mitotic activity was examined using pH3 immunohistochem-
istry at stages 11–13 (Fig. 4  I). There was no significant in-
crease (P = 0.1059) in the number of pH3-positive cells on the 
MO-injected side at stage 11, by which time the otic placode 
is already specified. By stage 12, however, a significant in-
crease in the number of pH3-positive cells was observed (P 
= 0.0322), with control otic sections containing a mean of 
29.4 ± 3.14 dividing cells and KDM4B-MO otic sections con-
taining a mean of 39.6 ± 2.38 dividing cells (Fig. 4 I). Inter-
estingly, the total number of pH3-positive cells significantly 
declined at stage 13 (P = 0.0286), by which time the otic pit 
has formed, with KDM4B-MO vesicles exhibiting 6.6 ± 0.75, 
whereas control otic vesicles contained a mean of 11.6 ± 1.72. 
To determine if this reduction in cell proliferation is accom-
panied by cell death, we performed Caspase3 immunostaining 
in sections through the ear of KDM4B-MO–treated embryos 
(Fig.  4, C, F, and J). Accordingly, by stages 12 and 13, we 
observed a significant increase in cell death upon depletion 
of KDM4B (P = 0.0491).
Taken together with the morphological changes noted in 
Figs. 2 and 3, the results suggest that loss of KDM4B function 
causes a striking change in otic morphology accompanied by 
a transient increase in the number of placode cells in S phase 
and undergoing mitosis when the otic cup normally undergoes 
invagination, followed by cell death.
Figure 2. Kdm4b loss of function results in abnormal maintenance of 
H3K9me3 marks. (A and B) H3K9me3 immunostaining in wild-type (WT) 
embryos at stages 11 (A) and 13 (B), showing the distribution of the epi-
genetic mark within the otic placode. At stage 11, H3K9me3 is relatively 
uniform, whereas by stage 13, staining is restricted to the rim of the otic 
ectoderm. (C–F) Electroporation of KDM4B-MO (F’) followed by immunos-
taining for H3K9me3 at stage 13 (E and F) shows that the distribution 
of the epigenetic mark increases after KDM4B knockdown compared 
with the control side (C and D). Otic placode territories are indicated by 
dashed outlines. Bars, 20 µm.
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Figure 3. KDM4B loss of function results in ear deformities and reduction in marker gene expression. (A–H) Electroporation of KDM4B-MO into the right side of the 
embryo (green staining in inset) causes a dramatic reduction in the otic placode domain as indicated by the expression of the otic placode markers Soho1, Pax2, 
Sox10, and Dlx3 in embryos examined at stages 12/13 (A–D), compared with the left uninjected side and control-MO–treated embryos (E–H). Transverse sections 
(A’–D’) reveal disorganization of the otic tissue. (I) RT-qPCR analyses show a consistent reduction in Dlx3 and SOHo1 expression, but moderate for Sox10 and Pax2, 
on the KDM4B-MO–injected side (IS) compared with the uninjected side (UIS). Vertical bars represent the ΔΔCt ratio between the injected and uninjected side from 
the same pool of embryos. Vertical error bars on data points represent the standard error of mean obtained from three independent samples, including eight otic 
vesicles on each. Horizontal dotted line indicates the threshold ΔΔCt ratio (injected side/uninjected side = 1). (J) Western blot analysis, performed from 16 isolated 
otic vesicles, reveals a 36% reduction of KDM4B protein expression on the KDM4B-MO–injected side compared with the  uninjected side. (K–M) Electroporation of 
KDM4B-MO (green fluorescence in inset), together with a vector containing the coding region of KDM4B, rescues the depletion of SOHo1 as assayed by ISH and 
the otic placode invagination (L). In contrast, coelectroporation of KDM4B-MO plus an empty vector (K) or catalytically dead mutant of Kdm4b (KDM4BΔ; M) failed 
to rescue the loss-of-function phenotype (see Fig. S2 for phenotypes quantitation). Bars: (A–H and K–M) 200 µm; (A’–D’) 20 µm.
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Knockdown of KDM4B affects the 
polarization of adhesion molecules  
on otic placode cells
During otic placode invagination, epithelial cells undergo shape 
changes mediated intracellularly by cytoskeletal changes and 
extracellularly by cell adhesion molecules. This leads to pro-
gressive invagination, ending with closure to form the otocyst 
(Gerchman et al., 1995; Moro-Balbás et al., 2000). Morpho-
metric studies have shown that otic invagination is biphasic. 
Phase one involves a basal expansion to make the initial de-
pression, and phase two comprises an apical constriction that 
guides the gradual hollowing of the otic vesicle (Alvarez and 
Navascués, 1990; Sai and Ladher, 2008; Sai et al., 2014). 
During apical constriction phases, epithelial cells express cad-
herin adhesion molecules, well known for their involvement in 
cell–cell adhesion events during embryonic development (Mar-
tin and Goldstein, 2014).
The profound changes in epithelial cell shape within 
the otic placode after KDM4B knockdown raised the in-
triguing possibility that this phenotype might be accom-
panied by changes in adhesive interactions between the 
cells. To examine this possibility, we analyzed the effects 
of KDM4B knockdown on the localization of E-cadherin 
(E-cad), the cadherin most prominently expressed through-
out the embryonic ectoderm (Fig.  5). At stage 12, E-cad 
was enriched uniformly along cell membranes in control 
otic vesicles (Fig.  5  A), clearly revealing cell shapes that 
were oriented along the apical–basal axis. In stark contrast, 
KDM4B-MO–treated otic cells exhibited a nonuniform and 
disorganized distribution of E-cad along their membranes 
(Fig.  5  B), revealing perturbed cell shapes and suggesting 
that cadherin-mediated adhesion was disrupted. To further 
investigate this, we analyzed the distribution of β-catenin, a 
component of the cadherin-mediated adhesion complex. At 
stage 12, β-catenin was enriched along the apical surface of 
control otic vesicles, during which time the otic placode was 
invaginating (Fig. 5 C). In contrast, β-catenin localization in 
KDM4B-MO–treated otic tissue was not apically enriched, 
but instead, it was disorganized (Fig. 5 D), in agreement with 
observations of E-cad distribution.
We next assessed E-cad distribution and apical constric-
tion at stage 13. Although on the control side the distribution 
of E-cad was polarized, localized to the apical side of invagi-
nating placode cells (Fig. 5 E), E-cad was not apically enriched 
on the KDM4B-MO–electroporated side. Instead, it appeared 
evenly distributed along the cell membrane of all placodal 
Figure 4. Depletion of KDM4B protein transiently 
increases cell proliferation and cell death. BrdU as-
says (A, D, and G), cell counts (B, E, and H), and 
pH3 immunostaining (I) performed on KDM4B-MO–
treated embryos reveal a transient increase in 
cell proliferation at stage 12. At stages 12/13, 
there was an increase in cell death observed with 
Caspase3 immunostaining (C, F, and J) on the 
KDM4B-MO–treated side compared with the con-
trol side. Dashed lines outline the otic placodes in 
A–F. Error bars indicate ±SEM. **, P < 0.05 with 
Student’s t test. Bars, 40 µm.
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cells, which appeared to have lost polarity (Fig. 5 F). Indeed, 
the morphology of the otic placode was disorganized and in-
vagination failed. During normal otic placode development, 
actin filaments exhibit an apical-to-basal polarity and upon in-
vagination are rearranged and become enriched apically (Sai 
and Ladher, 2008). After KDM4B loss of function, however, 
phalloidin staining revealed a loss of actin filament polarity 
(Fig. 5 F) compared with the control side (Fig. 5 E). To quanti-
tate the change of cell polarity during the invagination process, 
we measured the nuclear angles, toward a horizontal median, 
along the mediolateral axis in transverse sections stained with 
Hoechst. This analysis revealed a lack of a proper nuclear 
orientation and columnar morphology on the KDM4B-MO–
treated side compared with the untreated side (Fig. S4).
Figure 5. Depletion of KDM4B affects the polarization of adhesion molecules on otic placode cells. Subcellular localization of E-cad, β-catenin, and phal-
loidin staining by stages 12 (A–D) and 13 (E and F) at the onset of otic invagination on the control- (A, C, and E) and KDM4B-MO–treated sides (B, D, and 
F). The results show mislocalization of E-cad and β-catenin at stage 12 as well as disorganization of actin filaments, as revealed by phalloidin staining, on 
the KDM4B-MO–injected compared with the uninjected side in stage 13. Bars: (A–F) 50 µm; (A’–D’) 20 µm.
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Thus, actin filament polarity as well as E-cad and β-catenin 
distribution appear mislocalized after reduction of KDM4B, ac-
companied by misalignment of otic cells. Collectively, the re-
sults suggest that the failure of proper otic invagination after 
exposure to KDM4B-MO may reflect impairment of cell–cell 
interactions and cell polarization.
KDM4B binds to the Dlx3 regulatory 
region and is required for demethylation  
of H3K9me3 at the Dlx3 promoter
To test whether KDM4B may directly regulate otic marker gene 
expression by histone demethylation, which in turn impacts 
otic invagination, we examined whether the histone demethy-
lase directly interacts with regulatory regions of key otic tran-
scription factors. To this end, we performed in vivo ChIP-qPCR 
on ∼30–40 dissected otic placodes from embryos at stage 11 
using an anti-KDM4B antibody. We tested the occupancy of 
the KDM4B protein on regulatory regions of SOHo1, Pax2, and 
Dlx3 genes (Fig. 6). Although no binding was observed to the 
known chromatic regions of SOHo1 and Pax2 (Fig. 6, A and 
B), we observed consistent binding to the first intron (1 kbp from 
the transcription start site [TSS]), but not to the promoter of 
the Dlx3 gene at stage 11 (Fig. 6 C). Interestingly, this strong 
binding did not persist at stage 13 (Fig. 6 C), suggesting dy-
namic and transient regulation mediated by KDM4B during 
inner ear development.
We next assayed for H3K9me3 occupancy and observed 
pronounced enrichment of this epigenetic mark in the pro-
moter region (−0.5 kbp from the TSS) of Dlx3 at stage 11, 
also greatly diminished by stage 13 (Fig. 6 D). To demonstrate 
specificity, we repeated the ChIP with both anti-KDM4B and 
anti-H3K9me3 after KDM4B-MO knockdown. As predicted, 
the KDM4B occupancy on the Dlx3 locus at stage 11 was 
greatly reduced after treatment with KDM4B-MO– compared 
with control-MO–treated embryos (Fig.  6  E). Reciprocally, 
H3K9me3 occupancy on the Dlx3 promoter clearly increased in 
KDM4B-MO–treated embryos, consistent with removal of de-
methylase activity. Collectively, these results demonstrate that 
Figure 6. Endogenous KDM4B binds to a regulatory 
region of Dlx3 locus during inner ear invagination. 
(A–C) In vivo ChIP-qPCR assays were used to assess 
KDM4B binding to genes implicated in ear develop-
ment such as Soho1 (A), Pax2 (B), and Dlx3 (C). The 
vertical axes represent fold enrichment (specific ChIP/
IgG enriched), and the numbers on the horizontal 
axes represent distances in kilobase pairs with re-
spect to the TSS on the analyzed genes. Error bars 
show standard deviation. Schematic diagrams at the 
top show primer locations for each analyzed gene. 
One representative sample out of three independent 
experiments is depicted. The results show that KDM4B 
strongly associates with the Dlx3 gene at the first in-
tron (C), but not to SOHo1 (A) or Pax2 (B) at stage 11. 
This association was greatly diminished at stage 13 
(C). (D) The results show high occupancy of H3K9me3 
at −0.5 kb from the TSS of Dlx3 at stage 11, though 
the repressive mark is clearly reduced by stage 13. 
(E) ChIP assays were performed on ∼20–30 stage 11 
otic placodes from KDM4B-MO– and control-MO–
treated embryos. The results show a lack of KDM4B 
binding to the Dlx3 locus on KDM4B-MO– compared 
with control-MO–treated embryos. (F) H3K9me3 oc-
cupancy was greatly increased when knocking down 
KDM4B on the promoter region of Dlx3.
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KDM4B is recruited in proximity to the first intron of Dlx3, and 
its activity is responsible for demethylation of the H3K9me3 
mark at the promoter of the Dlx3 gene.
DLX3 is sufficient to rescue invagination 
defects after KDM4B knockdown
The ChIP data suggest that KDM4B may affect otic invagi-
nation via regulation of Dlx3 expression. To test this hypoth-
esis, we next asked whether adding back DLX3 would rescue 
the effects of KDM4B loss. To this end, we coelectroporated 
KDM4B-MO together with an expression construct containing 
the Dlx3 coding sequence into otic ectoderm at stage 8. Embryos 
were sorted for severity of phenotypes and immunostained for 
E-cad and phalloidin at stage 12/13 to assess the invagination 
phenotype. Remarkably, Dlx3 expression was sufficient to res-
cue the severity of the phenotypes compared with KDM4B-MO 
plus empty vector (Fig. 7 and Fig. S5). Phenotype quantitation 
showed that 80% of the analyzed embryos exhibited no otic in-
vagination defects and displayed rescued otic vesicle size (Fig. 
S5, B and D), whereas 36% and 47% of embryos electropo-
rated with KDM4B-MO plus empty vector exhibited strong and 
mild invagination phenotypes, respectively (Fig. S5, A and D). 
Immunohistochemistry revealed that E-cad distribution, actin 
polarity, and invagination (Fig.  7, A–I), as well as cell death 
(Fig. S5, E–G and K), were strikingly rescued after coelectro-
poration of KDM4B-MO with the Dlx3 expression construct. 
In contrast, coelectroporation of KDM4B-MO plus an expres-
sion vector containing the Dlx5 gene, another Dlx factor that 
is expressed during otic placode development, was not suffi-
cient to rescue invagination defects (Fig. S5, C, D, and H–J). 
Collectively, these data show that KDM4B histone demethylase 
epigenetically influences otic placode invagination via modulat-
ing Dlx3 gene expression.
Knockdown of Dlx3 causes similar 
phenotypes to KDM4B loss
As Dlx3 expression was sufficient to rescue otic defects after 
knockdown of KDM4B, we postulated that DLX3 plays 
a key functional role during otic placode invagination. To 
test this hypothesis, we performed DLX3 loss-of-function 
Figure 7. Coelectroporation of KDM4B-MO with pCIG-Dlx3 was sufficient to rescue otic invagination. Using immunohistochemistry, the control side (A–C) 
shows normal invagination as visualized by E-cad and phalloidin staining, but disrupted invagination on the KDM4B-MO–treated side (D–F). Coexpres-
sion of Dlx3 (G–I) with KDM4B-MO was sufficient to rescue otic invagination, leading to a proper arrangement of actin filaments and correct localiza-
tion of E-cad. Bars, 50 µm.
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experiments by electroporating a fluorescein-tagged an-
tisense MO into the otic ectoderm at stage 8.  At stage 12, 
DLX3 loss resulted in a failure in otic placode invagination 
(Fig. 8 B) when compared with the control side (Fig. 8 A). 
Apical accumulation of actin, as viewed by phalloidin, was 
also compromised compared with the control (Fig. 8, A′ and 
B′), indicating that the cellular rearrangements necessary for 
invagination failed to occur in a timely manner. These data 
show that Dlx3 is one of the key genes required for proper 
otic placode morphogenesis.
Discussion
After its induction, the otic placode undergoes morphogene-
sis that transforms it from a flat ectodermal disk to a hollow 
internalized spherical vesicle. Experiments using otic placode 
explants have provided evidence that the invagination pro-
cess occurs as a consequence of extrinsic signals that trigger 
a specific transcriptional program (Sai and Ladher, 2008). In 
addition, epigenetic modifications are gaining recognition 
as key regulators in the fine-tuning of gene expression and 
cell differentiation. In this study, we show that in addition to 
external signaling events, intrinsic epigenetic programs are 
necessary for proper otic morphogenesis. Our results demon-
strate that the histone demethylase KDM4B is critical for otic 
invagination, with its loss causing abnormal ear morphogen-
esis. Moreover, we show that KDM4B functions by directly 
controlling expression of the Dlx3 gene, in a spatiotemporally 
regulated manner, through H3K9me3 removal. These data re-
veal for the first time an epigenetic contribution to the control 
of inner ear invagination in vertebrate embryos via modulation 
of histone methylation.
Our finding that Dlx3 is a direct target of KDM4B is 
consistent with the similar spatiotemporal expression pat-
terns of Kdm4b (present study) and Dlx3 (Brown et al., 2005) 
transcripts during inner ear development. Like Kdm4b, Dlx3 
is highly expressed throughout the entire chick otic placode 
at stage 11, and its expression becomes restricted to the rim 
of the otic pit as invagination proceeds (Brown et al., 2005). 
Our results show that KDM4B abundantly occupies the first 
intron of Dlx3, from which it exercises its demethylase activ-
ity on the H3K9me3 mark located at the promoter region of 
the gene. We speculate that the first intron of Dlx3 may act as a 
KDM4B-recruiting element, thus allowing H3K9me3 removal 
and gene activation. Related to this, some studies have sug-
gested that first introns may play a vital role in transcriptional 
regulation of genes (Majewski and Ott, 2002; Li et al., 2012). 
As a general trend, first introns are longer, highly conserved, 
and enriched in CpG dinucleotides compared with other in-
trons (Majewski and Ott, 2002; Kalari et al., 2006; Bradnam 
and Korf, 2008; Park et al., 2014), suggesting that they may 
contain regulatory elements. The methylation of CpG dinu-
cleotide is also known to be involved in transcriptional reg-
ulation of genes by modifying chromatin structure and/or 
altering binding sites of transcription factors (Siegfried et al., 
1999; Campanero et al., 2000). Dlx3 is no exception, as its 
first intron is embedded within a large CpG island, suggesting 
that this may play a critical role in recruitment of transcription 
factors necessary for its regulation. Interestingly, Park et al. 
(2014) have shown that first introns are enriched in active tran-
scriptional chromatin marks such as H3K4me3/me1. Related 
to this, there is evidence that double Tudor domains, present 
in KDM4 proteins, may recognize the H3K4me3 marks nec-
essary for their recruitment to target chromatin regions (Sims 
et al., 2007; Lee et al., 2008).
Interestingly, Dlx3 has been suggested to play a role in 
the regulation of extracellular matrix and adhesion molecules 
during the otic invagination process (Gerchman et al., 1995; 
Moro-Balbás et al., 2000; Visconti and Hilfer, 2002). Con-
sistent with this, injection of function-blocking antibodies to 
perturb the extracellular matrix prevents association of the 
otic primordium with the hindbrain and inhibits subsequent 
invagination (Moro-Balbás et al., 2000; Visconti and Hilfer, 
2002). Oriented actin filaments and adhesion molecules, like 
E-cad and adherent junction proteins, have been shown to play 
an essential role in collective migration processes, including 
otic placode invagination (Borges et al., 2011; Theveneau et 
al., 2013; Sai et al., 2014). Otic invagination occurs in a bi-
phasic manner, initiating with basal expansion to generate the 
initial depression followed by apical constriction to drive the 
deepening of the otocyst (Sai et al., 2014). During the first 
Figure 8. Knockdown of Dlx3 results in failure of otic 
invagination. The control side (A) shows normal invagi-
nation as seen by apical accumulation of actin filaments 
viewed by phalloidin staining. The electroporation of 
DLX3-MO compromise otic invagination (B), indicated 
by irregular rearrangement of actin filaments. (A’ and 
B’) Inset views indicate the lack of apical accumulation 
of actin filaments on the injected side. Bars: (A and B) 
60 µm; (A’ and B’) 20 µm.
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phase, extrinsic FGF signaling coordinates the depletion of 
basal actin filaments producing basal expansion of otic plac-
ode cells (Sai and Ladher, 2008). The second phase, which 
is regulated in a RhoA–Rho-associated protein kinase–de-
pendent manner, results in myosin II activation necessary to 
direct the contraction of the apical actin networks that results 
in apical constriction (Sai et al., 2014). These observed cy-
toskeletal changes necessary for proper otic placode invag-
ination are similar to those perturbed by a KDM4B loss of 
function. In the present study, we noted a clear mislocaliza-
tion of actin filaments and E-cad molecules, along with im-
proper ear invagination.
The morphological changes observed after KDM4B 
loss correlated with a transient increase in cell proliferation at 
stages 11/12, which is the transitional stage during which the 
ectodermal invagination process initiates and gradually leads 
to the internalization of the developing ear. Then, at stage 13, 
we noted a cessation in cell proliferation and a significant in-
crease in cell death. Collectively, we propose that after a loss 
of KDM4B, otic placode cells are unable to exit the cell cycle, 
and that this lack of early differentiation/invagination leads 
to apoptosis. Cell death normally occurs concomitant with 
invagination movements and proliferative activity in the otic 
epithelium (Represa et al., 1990). Based on this, we hypoth-
esize that alteration in the proliferation/death balance may 
also contribute to defects in otic morphological development, 
mainly by affecting the cell–cell interactions necessary for 
correct tissue folding.
The present data support an important role for Dlx3 
in otic invagination. Our loss-of-function experiments show 
that a DLX3 loss results in failure in otic invagination and 
striking morphological changes, including irregular accumu-
lation of actin filaments. These observations are consistent 
with previous work in zebrafish showing that MO-mediated 
reduction of Dlx3b (Dlx3 homologous) delays specification 
of the otic placode and impairs complete maturation of the 
otic vesicle, resulting in formation of a smaller vesicle (Liu 
et al., 2003; Hans et al., 2004). Although the mechanistic 
link between Dlx genes and ear morphogenesis has yet to be 
elucidated, clues to its function may be gleaned from other 
systems. For example, during interneuron migration, Dlx 
genes are known to repress PAK3 (member of the p21-ac-
tivated serine/threonine kinases family) that is required for 
cytoskeletal rearrangements (Cobos et al., 2007). PAK ki-
nases are major downstream effectors of the Rho GTPases 
Rac1 and Cdc42 (Bokoch, 2003; Hofmann et al., 2004). In 
turn, Rho GTPases are thought to act as integrators of intrin-
sic and extrinsic signals to orchestrate cytoskeletal changes 
that influence cell motility (Luo, 2000; Govek et al., 2005) 
and apical constriction (Martin and Goldstein, 2014). Ac-
cordingly, in the developing otic placode, we speculate that 
intrinsic epigenetic regulation of the Dlx3 gene may affect 
the expression of analogous targets that in turn may control 
cytoskeletal rearrangements during ear development.
In summary, we provide strong evidence that early epi-
genetic influences are critical for regulating expression of 
transcription factors, most notably Dlx3, in the developing ear. 
Perturbation of this epigenetic fine-tuning leads to major down-
stream defects in ear formation. These results highlight the im-
portance of and close connection between transcriptional and 
epigenetic regulatory programs during development in general 
and of the forming ear in particular.
Materials and methods
Embryos
Fertilized chicken eggs were obtained from local commercial sources 
and incubated at 38°C to the desired stages according to the criteria of 
Hamburger and Hamilton.
Electroporation, MOs, and rescue experiments
An antisense MO oligomer to KDM4B was designed against a se-
quence near the ATG codon (5′-GTT TTCAG ACCCC ATATT TCCAG 
GA-3′) and against DLX3 near the ATG codon (5′-TCT TGTCG 
AAGGA GCCGC TCATC GC-3′). As a control, we used the standard 
control-MO (5′-CCT CTTAC CTCAG TTACA ATTTA TA-3′; Gene Tools, 
LLC). Injections of fluorescein-tagged MO (1–2-mM plus 0.3 µg/µl of 
plasmid DNA) and vectors, on the right side of the embryos, were 
performed by air pressure using a glass micropipette targeted to the 
presumptive otic placode region at stage 8, located lateral to somites 1 
and 2. Electroporation was performed with five pulses of 8 V in inter-
vals (30 ms on and 100 ms off). For rescue experiments, the construct 
included the coding region of KDM4B, the catalytically dead mutant 
(KDM4BΔ), Dlx3, or Dlx5 in a pCI-IRES-H2BGFP vector. The 
pCIG-Dlx3 and pCIG-Dlx5 constructs were provided by M. Barem-
baum (Division of Biology and Biological Engineering, California 
Institute of Technology, Pasadena, CA). For each embryo, 1-mM MO 
and 1 µg/µl DNA was used for KDM4B rescue and 1-mM MO and 1.5 
µg/µl DNA for Dlx3 and Dlx5 rescue. KDM4BΔ was obtained by fu-
sion PCR (Table S1) mutating specific amino acids (H189A, F186A, 
and E191Q), described to be necessary for the demethylation activity 
of KDM4B (Fodor et al., 2006; Beyer et al., 2008; Kawazu et al., 
2011), and then cloned into pCIG-IRES-H2B-RFP vector. We have 
confirmed that both vectors, containing KDM4B and KDM4BΔ, ex-
hibit strong protein expression, as they were immunodetected in the 
nucleus of electroporated cells by using an anti-KDM4B antibody 
(rabbit anti-KDM4B; Novus Biologicals). Moreover, we have also 
demonstrated that KDM4B, but not KDM4BΔ, overexpression was 
able to erase the H3K9me3 modification on electroporated cells (Fig. S3).
After electroporation, eggs were sealed with tape and incu-
bated to reach the desired stages. Embryos were removed from eggs, 
placed in PBS, and viewed and photographed as whole mounts using 
a fluorescence stereomicroscope to assay electroporation efficiency 
within the otic domain.
ISH
Whole-mount ISH was performed as previously described (Aclo-
que et al., 2008). Embryos were fixed overnight in 4% PFA at 4°C, 
washed in PBSw-DEPC (PBS-diethylpyrocarbonate containing 0.1% 
Tween), and dehydrated in MeOH/PBSw-DEPC series at RT before 
being stored at −20°C in 100% MeOH. After being rehydrated step-
wise with decreasing concentrations of MeOH/ PBSw-DEPC Tween 
0.1% and then washed three times with PBSw-DEPC, embryos were 
permeabilized using 10 µg/µl proteinase K at RT. Embryos were then 
hybridized at 70°C overnight with the desired digoxigenin (DIG)-la-
beled RNA probe. DIG-labeled RNA probes were synthesized from 
pCI plasmids containing the following cDNAs: Kdm4b, Dlx3, Pax2, 
SOHo1, and Sox10. Hybridized probes were detected using an alka-
line phosphatase–conjugated anti-DIG antibody (1:2,000; Roche) in 
the presence of nitroblue tetrazolium/5-bromo-4-chloro-3-indolyphos-
phate substrates (Roche). Whole-mount pictures were taken at RT 
using AxioVision software (Carl Zeiss) with a microscope (Stemi SVII; 
Carl Zeiss), or with the software Image-Pro Plus 5.1 Biological (Media 
Cybernetics) with a camera (Evolution VF; Media Cybernetics) in a 
microscope (SMZ800; Nikon). After ISH, some embryos were fixed in 
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4% PFA in PBS, washed, embedded in gelatin, and cryostat sectioned 
at a thickness of 14–16 µm. They were photographed using the Axio-
Vision software with a microscope (Axioskop 2 Plus; Carl Zeiss) and 
processed using Photoshop (CS3; Adobe).
Western blot
Otic vesicles were dissected from 16 unilaterally electroporated em-
bryos with KDM4B-MO and snap frozen in liquid nitrogen and stored 
at −80°C. Afterward, the injected and uninjected pool of otic vesicles 
were lysed by homogenization using a plunger and 150 µl of protein 
extraction buffer (50-mM Tris-HCl, pH 7.5, 100-mM NaCl, and 5-mM 
EDTA) supplemented with protease inhibitor (Complete Protease 
Inhibitor; Roche) and 1% of NP-40. Subsequently, they were centri-
fuged for 5 min at 1,000 g at 4°C, and the supernatant containing the 
proteins was collected. Proteins were quantified by Bradford, and an 
equal amount was run into an SDS-PAGE and transferred to a mem-
brane for blotting. Rabbit anti-KDM4B (Novus Biologicals) was di-
luted 1:1,000 to test the reduction in KDM4B protein, and a mouse 
antitubulin (Sigma-Aldrich) was diluted 1:2,000 as a loading control. 
Both primary antibodies were incubated overnight at 4°C.  Finally, 
secondary conjugated goat anti–mouse HRP or anti–rabbit HRP was 
diluted 1:10,000 and incubated for 45 min at RT for posterior devel-
oping by using ECL plus reagents according to the manufacturer’s in-
structions (GE Healthcare).
Immunohistochemistry
Fixed embryos were washed in 1× TBST (500-mM Tris-HCl, pH 
7.4, 1.5-M NaCl, 10-mM CaCl2, and 0.5% Triton X-100) and subse-
quently blocked in 10% donkey serum in 1× TBST for 3–5 h at RT. 
Embryos were then incubated in either mouse anti–E-cad (1:1,000; 
610181; BD), mouse anti–β-catenin (1:1,000; 6301; Abcam), rabbit 
anti-H3K9me3 (1:500; 8898; Abcam), rabbit anti-FITC (1:500; 71–
1900; Invitrogen), goat anti-FITC (1:500; NB600-493; Novus Biologi-
cals), or rabbit anti-Caspase3 (1:500; AF835; R&D Systems) overnight 
at 4°C. The secondary antibodies used were goat or donkey anti–mouse, 
donkey anti–goat, and anti–rabbit Alexa Fluor 350, 488, 594, and 647 
(1:1,000; Molecular Probes), which were incubated for 45 min to 3 h at 
RT. After washes, embryos were briefly postfixed for 10 min at RT in 
4% PFA, washed in 1× PBS, incubated in 15% sucrose/1× PBS for 1 h, 
and then embedded in 7.5% gelatin and 15% sucrose for cryosection-
ing. Sections of embryos were then incubated in 1:100 phalloidin 568 
and/or Hoechst 3358 (1:2,000). Sections were then imaged on one of 
the following microscopes: Axioskop 2 Plus with AxioVision software; 
Zen software (Carl Zeiss) and a photon confocal microscope (LSM 710 
2; Carl Zeiss) using a plan-apochromat/.95 korr 40× oil objective; an 
Image.M2 Apoptome.2 microscope (Carl Zeiss) using a plan-apochro-
mat/.95 korr 40× oil objective; or the NIS-Elements AR4.00 software 
(Nikon) on a microscope (Eclipse E600; Nikon) using plan 10× 0.25 
and plan 40× 0.65 objectives.
qPCR
Three different batches of embryos were electroporated with 
KDM4B-MO unilaterally at stage 8 and incubated to stage 13. Otic 
placodes from the injected and the uninjected side were dissected sep-
arately. Total RNA was extracted using an RNAqueous-Micro isola-
tion kit (Ambion) according to the manufacturer’s instruction. After 
DNaseI-amplification grade (Invitrogen) treatment, 1 µg of total RNA 
was used for cDNA synthesis using SuperScriptII (Invitrogen) and ran-
dom hexamers (Roche). qPCR was performed using a 96-well plate in 
MX3005P equipment (Agilent Technologies). Each reaction was per-
formed using Fast Start Syber green (Roche) in a 15-µl volume. All the 
used primers (Table S1) were tested to have amplification efficiency 
ranging from 95 to 100%. The subsequent quantification method was 
done using the ΔΔCt method (threshold cycle). For a reference gene, 
we used a qPCR primer designed for the GAP DH gene. Gene expres-
sion levels are represented relative to GAP DH expression.
Proliferation assays
BrdU powder (Sigma-Aldrich) was dissolved (10  mM) in Ringer’s 
solution and applied directly under the vitelline membrane via a glass 
needle adjacent to the KDM4B-MO–electroporated embryos at stage 
11. Embryos were incubated at 38°C for 45 min and then fixed in 4% 
PFA for 25 min at RT for cryosectioning. Cryosections were briefly 
rehydrated with 1× PBS, incubated with 2-N HCl for 10 min at 37°C, 
and then immediately washed in PBS with Tween, blocked at RT, 
and incubated at 4°C overnight in mouse anti-BrdU (1:250; B8434; 
Sigma-Aldrich). For mitotic counts, sections of embryos treated with 
KDM4B-MO were incubated with an antibody against pH3 (1:500; 
EMD Millipore) and then detected using the secondary Alexa Fluor 
568 goat anti–rabbit (1:1,000). Nuclei were detected by incubating 
sections in Hoechst 3358 with the secondary. All cell counts were per-
formed within the otic ectoderm of KDM4B-MO–injected and –unin-
jected sides, and statistical significance was determined using Student’s 
t test (Prism; GraphPad Software). 
ChIP
Approximately 20–40 otic placodes/otic pits were dissected from stage 
11 and stage 13 embryos. The tissue was homogenized in nuclei ex-
traction buffer (0.25% NP-40, 0.25% Triton X-100, 10-mM Tris-HCl, 
pH 7.5, 3-mM CaCl2, 0.25-M sucrose, 1-mM DTT, 0.2-mM PMSF, and 
EDTA-free protease inhibitor [Roche]). Cells were cross-linked with 
1% formaldehyde for 10 min at RT, and the formaldehyde was then 
inactivated by the addition of 125-mM glycine for 5 min. Cross-linked 
cells were centrifuged, and the pellet was washed three times in cold 
PBS containing a protease inhibitor. The final pellet was snap frozen in 
liquid nitrogen and stored at –80°C until use. Cells were resuspended 
in nuclei extraction buffer and rehomogenized until the nuclei went 
to the solution. After the centrifugation, the pellet was resuspended in 
SDS-lysis buffer (1% SDS, 50-mM Tris-HCl, pH 8.0, 10-mM EDTA, 
and EDTA-free protease inhibitor), and 2 vol of ChIP dilution buffer 
(0.01% SDS, 1.2-mM EDTA, 16.7-mM Tris-HCl, pH 8.0, 167-mM 
NaCl, 1-mM DTT, 0.2-mM PMSF, and stock of Complete EDTA-free 
protease inhibitor) was added. Chromatin was sheared to 300–800-
bp fragments using a sonicator (amp: 30%; cycle: 30  s on and 30  s 
off) for 15 min and centrifuged, and the supernatant was split in three 
tubes for input sample, mock control (rabbit anti-IgG; Abcam), and 
target antibodies of rabbit anti-KDM4B (Novus Biologicals) or rabbit 
anti-H3K9me3 (Abcam), all bound to protein A magnetic beads (Invi-
trogen). IgG and target antibodies (10 µg) were incubated overnight at 
4°C, and after extensive washes with radioimmunoprecipitation assay 
buffer (50-mM Hepes-KOH, pH 8, 500-mM LiCl, 1-mM EDTA, 1% 
NP-40, 0.7% Na-deoxycholate, 1-mM DTT, 0.2-mM PMSF, and a 
stock of complete protease inhibitor), the complexes were resuspended 
in an elution buffer (50-mM Tris-HCl, pH 8.0, 10-mM EDTA, and 1% 
SDS). The magnetic beads were eluted by incubating at 65°C for 15 
min and vortexing every 2 min and then were spun down at 16,000 g 
for 1 min at RT. The supernatant was reverse cross-linked by heating at 
65°C overnight. Immunoprecipitated DNA was treated with 0.2 µg/ml 
RNaseA and 0.2 µg/ml proteinase K, both for 1 h. Phenol/chloroform/
isoamyl alcohol extraction was performed followed by EtOH precip-
itation. Finally, the purified DNA was used as a template for qPCR 
analyses (see Table S1 for a list of primers). Each sample was loaded 
in triplicate, and the results were expressed as fold enrichment (spe-
cific ChIP/IgG enriched).
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Online supplemental material
Fig. S1 shows the expression of Kdm4b at early stages of otic 
development by ISH. Fig. S2 shows examples and quantitates the otic 
phenotypes observed in KDM4B-MO–treated embryos and rescued 
with a full-length or catalytically dead mutant of KDM4B. Fig. S3 
shows that electroporation with a vector containing the full length of 
KDM4B, but not the catalytically dead mutant KDM4BΔ, is capable 
of erasing the H3K9me3 mark. Fig. S4 shows that the depletion of 
KDM4B affects proper nuclear orientation in the invaginating otic 
placode. Fig. S5 shows that coelectroporation of KDM4B-MO with 
pCIG-Dlx3 was sufficient to rescue cell death and otic vesicle size, 
whereas coelectroporation of KDM4B-MO with pCIG-Dlx5 is not 
enough to rescue the phenotype. Table S1 lists all of the primers used 
for qPCR. Online supplemental material is available at http ://www .jcb 
.org /cgi /content /full /jcb .201503071 /DC1.
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